» Articles » PMID: 14607318

Dose-dependent Protective Effect of Coffee, Tea, and Smoking in Parkinson's Disease: a Study in Ethnic Chinese

Overview
Journal J Neurol Sci
Publisher Elsevier
Specialty Neurology
Date 2003 Nov 11
PMID 14607318
Citations 58
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Few studies have examined the relationship of coffee and tea in Parkinson's disease (PD). The potential protective effect of coffee intake and risk of PD has not been studied in a Chinese population. There is a high prevalence of caffeine takers among Chinese in our population.

Objective: We undertook a case control study to examine the relationship between coffee and tea drinking, cigarette smoking, and other enviromental factors and risk of PD among ethnic Chinese in our population.

Methods And Results: 300 PD and 500 population controls were initially screened. Two hundred case control pairs matched for age, gender, and race were finally included in the analysis. Univariate analysis revealed significant association of PD with coffee drinking (p<0.0005), tea drinking (p=0.019), alcohol drinking (p=0.001), cigarette smoking (p<0.0005), and exposure to heavy metals (p=0.006). Conditional logistic regression analysis demonstrated that amount of coffee drunk (OR 0.787, 95%CI 0.664-0.932, p=0.006), amount of tea drunk (OR 0.724, 95%CI 0.559-0.937, p=0.014), number of cigarettes smoked (OR 0.384, 95%CI 0.204-0.722, p=0.003), history of heavy metal and toxin exposure (OR 11.837, 95%CI 1.075-130.366, p=0.044), and heart disease (OR 5.518, 95%CI 1.377-22.116, p=0.016) to be significant factors associated with PD. One unit of coffee and tea (3 cups/day for 10 years) would lead to a 22% and 28% risk reduction of PD. One unit of cigarette smoke (3 packs/day for 10 years) reduced the risk of PD by 62%.

Conclusions: We demonstrated a dose-dependent protective effect of PD in coffee and tea drinkers and smokers in an ethnic Chinese population. A history of exposure to heavy metals increased the risk of PD, supporting the multifactorial etiologies of the disease.

Citing Articles

Relationship Between Depression and Epigallocatechin Gallate from the Perspective of Gut Microbiota: A Systematic Review.

Zhang Y, Liu C, Zhu Q, Wu H, Liu Z, Zeng L Nutrients. 2025; 17(2).

PMID: 39861389 PMC: 11767295. DOI: 10.3390/nu17020259.


Factors associated with phenoconversion of idiopathic rapid eye movement sleep behavior disorder: a prospective study.

Yuan Y, Li Y, Zhang H, Zang Y, Liu X, Hou Y NPJ Parkinsons Dis. 2025; 11(1):10.

PMID: 39762239 PMC: 11704329. DOI: 10.1038/s41531-024-00856-2.


Beta-Adrenergic Suppression of Neuroinflammation in Treatment of Parkinsonism, with Relevance for Neurodegenerative and Neoplastic Disorders.

Inchiosa Jr M Biomedicines. 2024; 12(8).

PMID: 39200184 PMC: 11351568. DOI: 10.3390/biomedicines12081720.


Neurodegenerative diseases and catechins: (-)-epigallocatechin-3-gallate is a modulator of chronic neuroinflammation and oxidative stress.

Li S, Wang Z, Liu G, Chen M Front Nutr. 2024; 11:1425839.

PMID: 39149548 PMC: 11326534. DOI: 10.3389/fnut.2024.1425839.


Caffeine intake interacts with Asian gene variants in Parkinson's disease: a study in 4488 subjects.

Ong Y, Deng X, Li H, Narasimhalu K, Chan L, Prakash K Lancet Reg Health West Pac. 2023; 40:100877.

PMID: 37691886 PMC: 10485627. DOI: 10.1016/j.lanwpc.2023.100877.